Treatment:
BI2536 S579-p
EGF S599-p , S999-p , S1001-p , S1003-p , T1005-p
ischemia S37-p , S40-p , S466-p , S794-p
lapatinib S45-p
LPA S636-p
metastatic potential S466-p , S601-p , T602-p , S794-p
nocodazole S37-p , S40-p , S999-p , S1001-p
SB202190 S599-p , S999-p , S1001-p , S1003-p , T1005-p
selumetinib S37-p , S40-p , S582-p
Su11274 Y28-p , Y353-p , Y924-p
U0126 S599-p , S999-p , S1003-p
vemurafenib S37-p , S40-p , S582-p
Y27632 S582-p